Solid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Rating of "Moderate Buy" by Brokerages
Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) has received an average recommendation of "Moderate Buy" from the twelve research firms that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and eleve...